Skip to content
Home/Companies/MedTech/Human Med
Human Med

Human Med

MedTech·Germany·Active·4yr hold
Entry
2022
Hold
4yr
Status
Active

Who owns Human Med?

Human Med is a German MedTech company, currently owned by PREMIUM Equity Partners since 2022.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
PREMIUM Equity Partners
Investor
PREMIUM Equity Partners
PREMIUM Mittelstand Fund II · 2020 · Small-Mid Buyout

Key facts

HQGermany
SectorMedTech
StatusActive
Websitewww.humanmed.com

More from PREMIUM Mittelstand Fund II

Other portfolio companies in the same fund.

color parts
Active
IndustrialsGermany· 2026
color parts GmbH
color parts GmbH
Active
IndustrialsGermany· 2026
FilaTech Group
FilaTech Group
Active
MedTechGermany· 2024
FREQCON GmbH
FREQCON GmbH
Active
EnergyGermany· 2023
heinekingmedia
heinekingmedia
Active
SoftwareGermany· 2021
LKE Group
LKE Group
Active
IndustrialsGermany· 2020

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Acufocus, Inc.
Exited 2023
The Carlyle GroupUS
to Bausch + Lomb
Adicon Holdings Limited
Active
The Carlyle GroupUS
Aesynt
Exited 2016
Francisco PartnersUS
to Omnicell
Alere Medical, Inc.
Active
TA AssociatesUS
Alma Lasers, Ltd.
Alma Lasers, Ltd.
Active
TA AssociatesIsrael
Amedes Group
Active
General AtlanticGermany

Questions

Who owns Human Med?

Human Med is currently owned by PREMIUM Equity Partners, through PREMIUM Mittelstand Fund II, since 2022.

When did PREMIUM Equity Partners acquire Human Med?

PREMIUM Equity Partners acquired Human Med in 2022.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue